NEW YORK (GenomeWeb News) — Eurofins Group yesterday said it has acquired three undisclosed companies in Germany, Japan, and the US that deal in custom DNA synthesis, analysis, and proteomic services.
Though Eurofins did not name the firms, it said together they employ around 200 people generated more than €20 million ($30 million) in 2006. The company said the acquisitions “should contribute positively” to the company’s financials “from 2008 onwards.” It did not elaborate.
“Through these acquisitions we will, together with our new partners, improve our market penetration in the area of molecular-biological research”, Eurofins CEO Gilles Martin said in a statement.
Financial terms of the acquisitions were not disclosed.
Eurofins provides testing and support services to the pharmaceutical, food, environmental, and consumer-products industries and to governments.
The company generates around $600 million in annual revenues. It employs 7,000 people across 100 sites in 27 countries.